Key Points In his view, it's now a buy. Its dividend yield is relatively low, however. 10 stocks we like better than Welltower › Investors owning Welltower (NYSE: WELL) were doing relatively well on Thursday. Shares of the healthcare-focused real estate investment trust ( REIT ) received an upgrade from an analyst who tracks its fortunes, making the stock more attractive. The company's shares bumped 1.6% higher on a day when the benchmark S&P 500 index essentially flatlined. Successfully Chased Before market open that day, Michael Mueller of JPMorgan Chase 's J.P. Morgan changed his rating on Welltower to overweight (read: buy) from his previous neutral. He also set a price target of $260 per share, which is 11% higher than Thursday's closing price.
Главную мысль мы показываем публично. Создайте бесплатный аккаунт, чтобы читать статью полностью, сохранять ее, обсуждать и связывать с рынками и OSINT-контекстом.